Status:
TERMINATED
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare efficacy and safety of Exubera® vs Humalog in patients with type 1 diabetes mellitus
Detailed Description
Pfizer announced in October 2007 that it would stop marketing Exubera®. At that time recruitment for study, A2171035 was placed on hold. Nektar, the company from which Pfizer licensed Exubera®, announ...
Eligibility Criteria
Inclusion
- Diabetes mellitus Type 1
Exclusion
- Severe Asthma, severe Chronic Obstructive Pulmonary Disease (COPD)
- Smoking
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00356421
Start Date
November 1 2006
End Date
June 1 2008
Last Update
September 2 2009
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Hamilton, New Jersey, United States, 08610
2
Pfizer Investigational Site
New Brunswick, New Jersey, United States, 08903
3
Pfizer Investigational Site
Vienna, Austria, A-1030
4
Pfizer Investigational Site
Vienna, Austria, A-1130